HXBM OTC
Helix BioMedix, Inc.
1W: -34.2%
1M: -45.2%
3M: +83.8%
YTD: +64.5%
1Y: -6.0%
3Y: -85.0%
5Y: -86.9%
$3.29
-1.11 (-25.28%)
Weekly Expected Move ±43.7%
$0
$2
$3
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.7M
52W Range1-6.5
Volume0
Avg Volume11
Beta1.37
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORobin L. Carmichael
Employees8
SectorHealthcare
IndustryBiotechnology
IPO Date1999-03-25
Websitehelixbiomedix.com
19125 Northcreek Parkway
Bothell, WA 98011
US
Bothell, WA 98011
US
425-402-8400
About Helix BioMedix, Inc.
Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company was founded in 1988 and is headquartered in Bothell, WA.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| BEATTY R STEPHEN | P-Purchase | 60,000 | $0.25 | 2003-12-26 |
| BEATTY R STEPHEN | J-Other | 25,000 | $2.25 | 2003-12-26 |
| BEATTY R STEPHEN | X-InTheMoney | 60,000 | $0.25 | 2003-12-26 |
| BEATTY R STEPHEN | J-Other | 25,000 | $3.25 | 2003-12-26 |